Entity Addresses, Address Type [Axis] Business Contact [Member] Related and Nonrelated Parties [Axis] Sanovas Ophthalmology LLC [Member] Related Party [Member] Class of Stock [Axis] Series F Preferred Stock [Member] Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Stock Subscription Receivable [Member] Retained Earnings [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Exchange Agreement [Member] Business Acquisition [Axis] D N A G P S Inc [Member] Vendor [Member] Antidilutive Securities [Axis] Share-Based Payment Arrangement, Option [Member] Pre-funded Warrant [Member] Warrant [Member] Title and Position [Axis] Officer [Member] Halo Management LLC [Member] Plan Name [Axis] 2017 Equity Incentive Plan [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Stock Option One [Member] Stock Option Two [Member] Jerry Katzman MD [Member] Virender Ahluwalia [Member] Herbert Gould MD [Member] Dessy Boneva MD [Member] Vinay Mehindru MD [Member] Warrant One [Member] Warrant Two [Member] Measurement Input Type [Axis] Measurement Input, Risk Free Interest Rate [Member] Measurement Input, Price Volatility [Member] Measurement Input, Expected Dividend Rate [Member] Measurement Input, Share Price [Member] Income Tax Authority, Name [Axis] Federal Income Tax [Member] Tax Period [Axis] No Expiration Date [Member] Expire in 2034 [Member] State Income Tax [Member] Entity Addresses [Table] Entity Addresses [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Contact Personnel Name Defined Benefit Plan [Table] Defined Benefit Plan Disclosure [Line Items] ASSETS Current Assets Cash Total Current Assets Equipment, net of accumulated depreciation of $276 and $251 at March 31, 2025 and December 31, 2024, respectively Operating lease right-of-use asset Security deposit TOTAL ASSETS LIABILITIES AND STOCKHOLDERS’ DEFICIT Liabilities Current Liabilities Accounts payable and accrued liabilities Due to related parties Shareholders’ notes payable Lease liability – short term portion Accrued interest payable Total Current Liabilities Lease liability – long term portion Total liabilities Stockholders’ Deficit: Preferred stock, $0.0001 par value; 40,000,000 shares authorized; Series F preferred stock - 3,000,000 shares designated, 0 issued and outstanding at March 31, 2025 and December 31, 2024 Common stock, $0.0001 par value; 80,000,000 shares authorized; 18,522,295 shares issued and outstanding at March 31, 2025 and December 31, 2024 Additional paid in capital Stock subscription receivable Accumulated deficit Total Stockholders’ Deficit TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT Statement [Table] Statement [Line Items] Accumulated depreciation Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenues Operating expenses: General and administrative Research and development Stock-based compensation Total operating expenses Interest expense, net Net loss Net loss per share, basic Net loss per share, diluted Weighted average number of common shares outstanding during the period- basic Weighted average number of common shares outstanding during the period- diluted Balance Balance, shares Balance Stock based compensation expense Net loss Retirement of due to Sanovas through the issuance of shares of common stock to Sanovas Ophthalmology LLC Retirement of due to Sanovas through the issuance of shares of common stock to Sanovas Ophthalmology LLC, shares Shares issued to investors Shares issued to investors, shares Settlement of account payable through issuance of common stock Settlement of account payable through issuance of common stock, shares Stock subscribed by investor Stock subscribed by investors, shares Stock issued to vendor Stock issued to vendor, shares Exercise of stock options Exercise of stock options, shares Collection of stock subscription receivable Balance Balance, shares Statement of Cash Flows [Abstract] Cash Flows From (Used In) Operating Activities Adjustments to reconcile net loss to net cash (used in) operating activities Non-cash items: Stock-based compensation expense Depreciation expense Stock issued for services provided Amortization of ROU asset Expenses allocated by Sanovas on behalf of Company Changes in operating assets and liabilities: Increase in accounts payable and accrued liabilities Increase in security deposit Payment of lease liability Increase in accrued interest Total adjustments Net cash (used in) operating activities Cash Flows From Financing Activities Proceeds from sale of common stock Proceeds from collection of stock subscription receivable Proceeds from exercise of stock options and warrants Advances from related parties Advances from related parties, net Net cash provided by financing activities Net increase (decrease) in cash Cash at beginning of period Cash at end of period Supplemental information: Interest paid Income taxes paid Operating lease at inception Retirement of due to Sanovas through the issuance of common stock to Sanovas Ophthalmology LLC (Note C) Settlement of account payable through the issuance of common stock Accounting Policies [Abstract] HISTORY, BUSINESS PURPOSE, LIQUIDITY AND GOING CONCERN SIGNIFICANT ACCOUNTING POLICIES Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Equity [Abstract] COMMON AND PREFERRED STOCK STOCK PLAN Warrants WARRANTS Debt Disclosure [Abstract] SHAREHOLDERS’ NOTES PAYABLE Lease LEASE Income Tax Disclosure [Abstract] INCOME TAXES Subsequent Events [Abstract] SUBSEQUENT EVENTS Basis of Presentation Cash Equivalents Use of Estimates Income Taxes Income (Loss) Per Common Share Stock-based compensation Research and Development costs Property and Equipment Leases Recent Accounting Pronouncements SCHEDULE OF RELATED PARTY TRANSACTIONS SCHEDULE OF STOCK OPTION ACTIVITY SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE SCHEDULE OF STOCK OPTIONS FAIR VALUE ASSUMPTIONS SCHEDULE OF WARRANTS ACTIVITY SCHEDULE OF WARRANTS OUTSTANDING SCHEDULE OF WARRANTS FAIR VALUE ASSUMPTIONS SCHEDULE OF LEASE LIABILITY MATURITY SCHEDULE OF LEASE-RELATED ASSETS AND LIABILITIES SCHEDULE OF DEFERRED TAX ASSETS Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Shares issued for acquisitions Accumulated deficit Liabilities Other liabilities Issuance of shares for settlement Payment of expenses Issuance of shares for settlement Payment for settlement Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive securities excluded from computation of earnings per share Property and equipment useful life Related Party Transaction [Table] Related Party Transaction [Line Items] Balance due to Sanovas – beginning of period Costs of Sanovas allocated to the Company Retirement of due to Sanovas through the issuance of shares to Sanovas Ophthalmology Cash advances from Sanovas to the Company, net Balance due to Sanovas - end of period Related party cost issuance of shares of common stock Advance funds received Stock, Class of Stock [Table] Class of Stock [Line Items] Preferred stock shares authorized Stock issued during period Share based compensation arrangement by share based payment award options cancelling Issuance of stock option were exercised Stock option exercised for cash payment Share offering price Proceeds from issuance of common stock Subscription receivable Preferred stock shares outstanding Preferred stock, voting right Preferred stock, protective features Preferred stock, dividend Preferred stock conversion basis Preferred stock conversion terms Proceeds from issuance of preferred stock Stock issued during period, values Options Issued, Options outstanding, beginning balance Weighted-Average Exercise Price, Options outstanding beginning balance Options Issued, Granted Weighted-Average Exercise Price, Granted Options Issued, Canceled Weighted-Average Exercise Price, Canceled Options Issued, Forfeited Weighted-Average Exercise Price, Forfeited Options Issued, Exercised Weighted-Average Exercise Price, Exercised Options Issued, Options outstanding, ending balance Weighted-Average Exercise Price, Options outstanding ending balance Options Issued, Forfeited Options Issued, Exercised Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Exercise Price Number Outstanding Weighted Average Remaining Contractual Life Number Exercisable Risk-free interest rates Expected life in years Expected volatility Expected dividend yield Fair value common stock Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Common stock shares reserved for future issuance Stock option expense Unrecognized compensation expense Weighted-average period for recognition Shares available for issuance Fair value of option grant price per share Schedule Of Warrants Activity Warrants Issued, Warrants outstanding, beginning balance Weighted-Average Exercise Price, Warrants outstanding, beginning balance Warrants Issued, Granted Weighted-Average Exercise Price, Granted Warrants Issued,Canceled and expired Weighted-Average Exercise Price, Canceled and expired Warrants Issued, Exercised Weighted-Average Exercise Price, Exercised Warrants Issued, Warrants outstanding, ending balance Weighted-Average Exercise Price, Warrants outstanding, ending balance Warrants Issued,Canceled and expired Exercise Price Number Outstanding Weighted Average Remaining Contractual Life Number Exercisable Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Warrant measurement input Expected life in years Warrant issued to purchase common stock Warrant exercise price Warrant shares Fair value of option grant price per share Common stock exchanged for warrants Debt instrument, face amount Interest rate Maturity date Extended maturity date Proceeds from exercise of warrants Notes payable Interest expense Accrued interest Schedule Of Lease Liability Maturity 2025 2026 2027 Total payments Less interest Total liability Schedule Of Lease-related Assets And Liabilities Right-of-use asset, net Lease liability -long term Lease liability – short term Lease description Operating lease term Security deposit Discount rate Lease payments Lease payments per month Lease payments over month Net operating loss carryforwards Accrued expenses Stock compensation Capitalized R&D costs, net Intangible asset, net Accrued interest Subtotal Less valuation allowance Net deferred tax asset Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Line Items] Description of operating loss carryforwards, limitations on use Operating loss carryforwards Gross deferred tax assets Deferred tax valuation allowance Stock Subscription Receivable [Member] Settlement of accounts payable through issuance of shares. Stock issued during period shares settlement of accounts payable. Sanovas Ophthalmology LLC [Member]. Vendor [Member] Pre-funded Warrant [Member] Costs of related party allocated. Halo Management LLC [Member] Stock issued during period shares stock subscribed by investors Stock subscription receivable 2017 Equity Incentive Plan [Member]. Stock Option One [Member] Stock Option Two [Member] Warrants Disclosure [Text Block] Jerry Katzman MD [Member] Virender Ahluwalia [Member] Herbert Gould MD [Member] Dessy Boneva MD [Member] Vinay Mehindru MD [Member] Share based compensation arrangement by share based payment award non-options outstanding weighted average exercise price granted. Share based compensation arrangement by share based payment award non-options outstanding weighted average exercise price. Share based compensation arrangement by share based payment award non-options outstanding weighted average exercise price cancelled. Share based compensation arrangement by share based payment award non-options outstanding weighted average exercise price exercised. Schedule Of Warrant Outstanding [Table Text Block] Warrant One [Member] Warrant Two [Member] Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average remaining contractual terms. Share based compensation arrangement by share based payment award non option equity instruments exercisableNumber. Schedule of share based payment award warrants valuation assumptions. Share based Compensation Arrangement By Share based Payment Award Warrant Fair Value Assumptions Expected Term 1. Exchange Agreement [Member] Schedule Of Lease Related Assets And Liabilities [Table Text Block] Stock issued during period value stock subscribed by investors. Operating lease at inception. Extended maturity date. Deferred tax assets tax stock compensation. Deferred tax assets capitalized research and development costs net. Deferred tax assets accrued interest. No Expiration Date [Member] Federal Income Tax [Member] State Income Tax [Member] Expire in 2034 [Member] Stockholder equity. Assets, Current Assets Liabilities, Current Liabilities [Default Label] Stockholders' Equity Note, Subscriptions Receivable Equity, Attributable to Parent Liabilities and Equity Operating Expenses Shares, Outstanding StockholderEquity Other Noncash Income (Expense) Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities Net Cash Provided by (Used in) Operating Activities Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Compensation Related Costs, Policy [Policy Text Block] Debt Conversion, Converted Instrument, Amount Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceGranted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceExercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantFairValueAssumptionsExpectedTerm1 Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Lessee, Operating Lease, Liability, to be Paid Operating Lease, Liability Lease Deposit Liability Deferred Tax Assets, Valuation Allowance Deferred Tax Assets, Net of Valuation Allowance